Nwam LLC Invests $1.48 Million in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Nwam LLC acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 14,926 shares of the exchange traded fund’s stock, valued at approximately $1,475,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Northwestern Mutual Wealth Management Co. lifted its position in SPDR S&P Biotech ETF by 1.6% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock valued at $106,158,000 after acquiring an additional 18,202 shares in the last quarter. Jane Street Group LLC lifted its position in SPDR S&P Biotech ETF by 68.7% in the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock valued at $91,197,000 after acquiring an additional 391,333 shares in the last quarter. Mirae Asset Securities USA Inc. lifted its position in SPDR S&P Biotech ETF by 50.0% in the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after acquiring an additional 300,000 shares in the last quarter. Employees Retirement System of Texas lifted its position in SPDR S&P Biotech ETF by 40.8% in the 2nd quarter. Employees Retirement System of Texas now owns 603,857 shares of the exchange traded fund’s stock valued at $55,984,000 after acquiring an additional 174,857 shares in the last quarter. Finally, Main Management Fund Advisors LLC lifted its position in SPDR S&P Biotech ETF by 8.3% in the 2nd quarter. Main Management Fund Advisors LLC now owns 598,200 shares of the exchange traded fund’s stock valued at $55,459,000 after acquiring an additional 45,700 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA XBI opened at $96.24 on Friday. SPDR S&P Biotech ETF has a fifty-two week low of $71.99 and a fifty-two week high of $105.47. The stock has a market cap of $7.34 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The firm’s 50-day simple moving average is $98.44 and its 200 day simple moving average is $96.23.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.